🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Investigational Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Followers are encouraged to contact these accounts directly for supplier links, while also obtaining discount codes.

Thriving Trade on Social Networks

Additionally, a robust market exists on Telegram, where communities with thousands of participants share “before and after” images, injection guides and claims of rapid British shipping. Vendors market the substance there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, physicians and chemists have cautions that the distribution of what is still an unapproved medication in the United Kingdom is worrisome and could result in individuals injecting substances of uncertain source.

Some experts said the popularity for the experimental drug could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach medicines, marketing, and consumer regulations, risking fines, prosecution or prison.

Platform Reaction and Content Elimination

According to the social media company, the platform has removed violative content and banned associated keywords and query recommendations. The organization stated it was committed to maintaining the platform safe and investing in strengthening enforcement strategies.

Digital Marketplace Operations

Research also discovered communities with up to nine thousand participants marketing retatrutide using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, populated with photos of weight loss, glowing reviews and step-by-step instructions for preparing or administering at home.

Within minutes of joining one group, a vendor posted contact information, where most purchases take place. The seller provided an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about body mass, medical conditions or previous experience.

Item Details and Costs

Inside these groups, posts display dark colored parcels with postal service stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with purified liquid, or ready-to-use pens usually sold at £160 for 20 milligrams. When asked how long a injector should be used, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Actions

A representative for the messaging service stated it actively monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering materials they cannot confirm. Even if the research behind this drug is sound, these digital versions may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of an online medical service linked the surge in demand to current price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she explained.

Her team has previously seen patients injured by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a Lilly investigational product not yet authorized … may subject patients to potentially serious health risks”.